LIVE
NIFTY 50
—
SENSEX
—
BANK NIFTY
—
FINNIFTY
—
INDIA VIX
—
NIFTY IT
—
NIFTY AUTO
—
NIFTY MID
—
GIFT NIFTY
—
USD/INR
—
NIFTY 50
—
SENSEX
—
BANK NIFTY
—
FINNIFTY
—
INDIA VIX
—
NIFTY IT
—
NIFTY AUTO
—
NIFTY MID
—
GIFT NIFTY
—
USD/INR
—
NIFTY 50
—
SENSEX
—
BANK NIFTY
—
FINNIFTY
—
INDIA VIX
—
NIFTY IT
—
NIFTY AUTO
—
NIFTY MID
—
GIFT NIFTY
—
USD/INR
—
Black Bear Labs
EN ▾
API
☆ Watchlist
Login
☰
✕
Login
☆ Watchlist
API Docs
Markets
NSE Stocks
BSE Stocks
F&O
Rates & G-Secs
Currencies
Sectors
Commodities
News
Corporate Announcements
Government & Policy
Fixed Income
ETFs
FX
Alt. Investing
Economic Calendar
Sections
Economics
Tech
Finance
Politics
Wealth
Language
English
हिन्दी
ગુજરાતી
मराठी
Markets ▾
Economics
Tech
Finance
Politics
Wealth
Home
/
Markets
/
Transcripts
/
MARKSANS
MARKSANS
NSE
Q1FY23
August 16, 2022
Marksans Pharma Limited
345
words
0
turns
0
analyst exchanges
2
executives
Download PDF ↗
MARKSANS stock page →
Management on call
Mark Saldanha
Founder, Chairman and Managing Director
Jitendra Sharma
Chief Financial Officer
Key numbers — 1 extracted
rs,
i — 400051 Symbol: MARKSANS BSE Limited Corporate Relation Department Phiroz Jeejeebhoy Towers, Dalal Street, Mumbai — 400001 Scrip Code: 524404 Subject: intimation of schedule of Earnings C
Advertisement
← All transcripts
MARKSANS stock page →
Market Movers
NIFTY 50
▼ 0.02%
NIFTY BANK
▼ 0.21%
NIFTY IT
▼ 0.65%
NIFTY MIDCAP 100
▲ 0.58%
NIFTY AUTO
▲ 1.73%
Updated 06:25 IST
Advertisement
Advertisement
Marksans Pharma Limited (MARKSANS) Earnings Call Transcript — Q1FY23 | Black Bear Labs | Black Bear Labs